Novel neurodevelopmental information revealed in amniotic fluid supernatant transcripts from fetuses with trisomies 18 and 21.
about
Noninvasive prenatal testing creates an opportunity for antenatal treatment of Down syndrome.Maternal obesity affects fetal neurodevelopmental and metabolic gene expression: a pilot study.The amniotic fluid transcriptome as a guide to understanding fetal disease.Amniotic fluid RNA gene expression profiling provides insights into the phenotype of Turner syndrome.Comparative Transcriptome Analysis of Cell-Free Fetal RNA from Amniotic Fluid and RNA from Amniocytes in Uncomplicated Pregnancies.microRNA Profiling of Amniotic Fluid: Evidence of Synergy of microRNAs in Fetal Development.Global gene expression analysis of term amniotic fluid cell-free fetal RNA.An Integrated Human/Murine Transcriptome and Pathway Approach To Identify Prenatal Treatments For Down Syndrome.What does next-generation sequencing mean for prenatal diagnosis?Measuring fetal brain and lung transcripts in amniotic fluid supernatant: a comparison of digital PCR and RT-qPCR methods.Transcriptome Profiling Uncovers Potential Common Mechanisms in Fetal Trisomies 18 and 21.QF-PCR rapid aneuploidy screen and aCGH analysis of cell free fetal (cff) DNA in supernatant of compromised amniotic fluids (AF).Global transcriptome dysregulation in second trimester fetuses with FMR1 expansions.Genetically induced abnormal cranial development in human trisomy 18 with holoprosencephaly: comparisons with the normal tempo of osteogenic-neural development.Aneuploidy: the impact of chromosome imbalance on nuclear organization and overall genome expression.Functional analysis of cell-free RNA using mid-trimester amniotic fluid supernatant in pregnancy with the fetal growth restriction.
P2860
Q34339997-B1603935-A586-4CD8-B552-647F37CB703AQ35099624-BD9834FD-D0DE-4983-B318-146A12226417Q35245269-678C44D4-30C2-4256-A83F-376DB05CD0F8Q35260595-0D7B5DCD-4284-40CD-AA02-9F5626B812D2Q35693396-EC7BD59D-9595-432A-A0B9-50B6EA69340CQ36014071-A102F7D5-CB97-4555-9002-8A1207C190F3Q37107647-EC65A2B5-2AB8-4CF3-AFC3-8114BB17A668Q37228171-398DE5BC-FE5C-4E99-B576-7254E0DEAE87Q38209384-916CB828-0942-4FCC-96A3-58795268849AQ40495571-AE80C08F-1FDD-4638-829D-6685B0F52D15Q42697864-F54EE829-CFA8-426F-AA23-5CE45E5184DEQ46624086-AC12F7D2-CC72-4278-9F73-59A47966579EQ47903193-666E35FA-8C24-4EA6-B9D8-718916ED0097Q48156828-AC685597-8DD3-4C6D-8B86-2DE04B86CFCDQ51710584-9D1E1864-918C-4237-9F20-052BC54BF3E2Q55114511-CDFE5C6F-D70B-4820-ACDA-E25098A4D8AD
P2860
Novel neurodevelopmental information revealed in amniotic fluid supernatant transcripts from fetuses with trisomies 18 and 21.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Novel neurodevelopmental infor ...... uses with trisomies 18 and 21.
@ast
Novel neurodevelopmental infor ...... uses with trisomies 18 and 21.
@en
type
label
Novel neurodevelopmental infor ...... uses with trisomies 18 and 21.
@ast
Novel neurodevelopmental infor ...... uses with trisomies 18 and 21.
@en
prefLabel
Novel neurodevelopmental infor ...... uses with trisomies 18 and 21.
@ast
Novel neurodevelopmental infor ...... uses with trisomies 18 and 21.
@en
P2093
P2860
P1433
P1476
Novel neurodevelopmental infor ...... tuses with trisomies 18 and 21
@en
P2093
Diana W Bianchi
Heather C Wick
Keiko Koide
Kirby L Johnson
P2860
P2888
P304
P356
10.1007/S00439-012-1195-X
P577
2012-07-03T00:00:00Z